These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25297773)

  • 21. [Acute promyelocytic leukemia associated with hemophagocytic syndrome].
    Jinta M; Arai A; Yamamoto K; Sakashita C; Fukuda T; Miu T; Koyama T; Murakami N; Miura O
    Rinsho Ketsueki; 2007 Apr; 48(4):310-4. PubMed ID: 17515122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tretinoin in pregnancy complicated with acute promyelocytic leukaemia.
    Leong KW; Teh A; Bosco JJ
    Med J Malaysia; 2000 Jun; 55(2):277-9. PubMed ID: 19839162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DIC Complicating APL Successfully Treated With Recombinant Thrombomodulin Alfa.
    Saito A; Okamoto Y; Seki Y; Matsunaga M; Nakagawa S; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e189-90. PubMed ID: 27123666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer and DIC.
    Levi M
    Haemostasis; 2001; 31 Suppl 1():47-8. PubMed ID: 11990477
    [No Abstract]   [Full Text] [Related]  

  • 26. Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.
    Takeuchi M; Tanoshima R; Miyagawa N; Sarashina T; Kato H; Kajiwara R; Ito S; Goto H
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27734584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolic risk in hematological malignancies.
    Franchini M
    Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism incidence in hematologic malignancies.
    Kekre N; Connors JM
    Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [2 cases of acute disseminated intravascular coagulation in normal pregnancy and as the first symptom of acute promyelocytic leukemia].
    Kardaszewicz E; Bujak M; Spychałowicz W; Siudyka A; Harbut-Gryłka A
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):257-9. PubMed ID: 2235704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy.
    Nomura S; Fujita S; Ozasa R; Nakanishi T; Miyaji M; Mori S; Ito T; Ishii K
    Platelets; 2011; 22(5):396-7. PubMed ID: 21438846
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
    Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
    Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of DIC associated with hematological malignancies].
    Seki Y
    Rinsho Ketsueki; 2018; 59(10):2212-2221. PubMed ID: 30305528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated Intravascular Coagulation (DIC) in cancer.
    Saba HI; Morelli GA; Saba RI
    Cancer Treat Res; 2009; 148():137-56. PubMed ID: 19377923
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
    Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical observation of low dose of heparin to treat coagulation disorders of acute promyelocytic leukemia].
    Chen S; Chen S; Yu Y; Chen J; Guo Y; Xu L; Zhang K; Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):459-60. PubMed ID: 24857222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.